PCN126 REAL-WORLD TREATMENT SEQUENCING OF ABIRATERONE AND ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC): WHAT ARE THE HEALTH ECONOMIC IMPLICATIONS?
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.322
https://www.valueinhealthjournal.com/article/S1098-3015(19)32700-7/fulltext
Title :
PCN126 REAL-WORLD TREATMENT SEQUENCING OF ABIRATERONE AND ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC): WHAT ARE THE HEALTH ECONOMIC IMPLICATIONS?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32700-7&doi=10.1016/j.jval.2019.09.322
First page :
Section Title :
Open access? :
No
Section Order :
10263